Navigation Links
CenTrak, a Leading Real-Time Location System Provider, Unveils New Branding
Date:11/3/2011

NEWTOWN, Pa., Nov. 3, 2011 /PRNewswire/ -- CenTrak, a leading Real-Time Location System provider for healthcare, is pleased to unveil its new brand positioning – The Smarter Real-Time Location System. The new messaging better captures all of the inherent advantages of the CenTrak RTLS

  • Industry-Leading Accuracy, Performance and Battery Life
  • Open Platform to Support Multiple Applications
  • Easy Installation and Maintenance

(Logo: http://photos.prnewswire.com/prnh/20111103/PH99163LOGO)

The new branding has been executed in all key foundational elements including the company's external website (www.centrak.com). 

"The new brand more closely captures CenTrak's personality, as well as our commitment to quality and performance – both being second-to-none. It positions us for continued growth and audience mindshare," said Dr. Ari Naim, CEO and Co-founder of CenTrak.

Adam Peck, Director of Marketing, who started at CenTrak in May 2011, drove the strategy for the new brand look and feel. "The new brand more clearly communicates the significant advantages and unique attributes inherent in the CenTrak infrastructure vital to growth of our industry. My first priority has been to establish a means to help expand the healthcare industry's understanding of the multitude of uses for real-time locating while demonstrating how CenTrak through unparalleled innovation, commitment to product quality and performance is enabling them."

About CenTrak

CenTrak™ is The Smarter Real-Time Location System™ (RTLS) – the leading provider of precise, adaptable, and cost-effective location solutions for healthcare facilities. The patented CenTrak Hybrid RTLS Technology™ uniquely combines Gen2IR and active RFID technologies to deliver certainty-based location data, a requirement for workflow and other key healthcare management applications. CenTrak delivers unmatched speed, performance and power-efficiency making it a smarter technology investment. As the only predominantly battery-powered RTLS network, CenTrak™ offers easy installation (no in-room wiring) as well as affordable enterprise-wide scalability. The CenTrak RTLS is in-use in over 15 million square feet of world-class healthcare facilities spanning three continents.

 


'/>"/>
SOURCE CenTrak
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
4. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
7. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
8. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
9. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
10. Patent Technologies Keep CGMT in a Leading Position in the Industry
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):